EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Analytical Challenges in Detecting New Psychoactive Substances in Anti‐Doping: A Proof‐of‐Concept Involving Pentedrone Metabolite

D Kwiatkowska iD, B Peta, K Grucza iD, A Łabęcka, P Konarski, K Wojtkowiak, K Grela, A Sytniczuk, M Wicka

Drug Testing and Analysis · 2026

DOI: 10.1002/dta.70047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2026. Verfasst von D Kwiatkowska und 8 weiteren Autor:innen. Beteiligte Einrichtung: PolishAnti-Doping Laboratory, Warsaw, Poland. Hauptthemen laut MEDLINE: Doping in Sports, Pentanones, Psychotropic Drugs, Substance Abuse Detection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New psychoactive substances (NPS) have become increasingly prevalent worldwide, posing a growing challenge to public health, forensic science, and doping control. Their structural diversity, rapid emergence, and legal ambiguity complicate both toxicological assessment and analytical detection. Research into the metabolism of these compounds is limited by ethical constraints on administration studies, hindering the development of reference standards. This study presents a methodological approach for the identification and confirmation of 2‐amino‐1‐phenylpentan‐1‐ol, a metabolite associated with several synthetic cathinones, including pentedrone, α ‐pyrrolidinopentiophenone (PVP), and N ‐ethylpentedrone (NEP). The compound was detected in a routine doping control sample using ultra‐performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS). In the absence of a commercially available certified reference material (CRM) encompassing all potential isomeric forms, a custom synthesis of the target metabolite was undertaken. The synthesized CRM‐enabled unambiguous confirmation of the analyte and its diastereomeric composition, demonstrating the importance of reference compound availability for the accurate interpretation of results in anti‐doping analysis. This work highlights both the analytical challenges posed by NPS and the need for continued development of tailored CRMs to support doping control laboratories worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsPentanonesPsychotropic DrugsSubstance Abuse DetectionHumansChromatography, High Pressure LiquidLiquid Chromatography-Mass SpectrometryPyrrolidinesReference StandardsTandem Mass SpectrometryMethylamines

Substanzen

PentanonespentedronePsychotropic DrugsPyrrolidinesMethylamines

Autor:innen und Institutionen

  • PolishAnti-Doping Laboratory, Warsaw, Poland.
  • Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.

ORCID-Profile: D Kwiatkowska, K Grucza

Förderung

  • Ministry of Health

Zitieren

APA

Kwiatkowska, D., Peta, B., Grucza, K., Łabęcka, A., Konarski, P., Wojtkowiak, K., Grela, K., Sytniczuk, A., & Wicka, M. (2026). Analytical Challenges in Detecting New Psychoactive Substances in Anti‐Doping: A Proof‐of‐Concept Involving Pentedrone Metabolite. Drug Testing and Analysis. https://doi.org/10.1002/dta.70047

Vancouver

Kwiatkowska D, Peta B, Grucza K, Łabęcka A, Konarski P, Wojtkowiak K, et al. Analytical Challenges in Detecting New Psychoactive Substances in Anti‐Doping: A Proof‐of‐Concept Involving Pentedrone Metabolite. Drug Testing and Analysis. 2026. doi:10.1002/dta.70047

BibTeX
@article{Kwiatkowska2026,
  author = {Kwiatkowska, D and Peta, B and Grucza, K and Łabęcka, A and Konarski, P and Wojtkowiak, K and Grela, K and Sytniczuk, A and Wicka, M},
  title = {Analytical Challenges in Detecting New Psychoactive Substances in Anti‐Doping: A Proof‐of‐Concept Involving Pentedrone Metabolite},
  journal = {Drug Testing and Analysis},
  year = {2026},
  doi = {10.1002/dta.70047}
}
Kostenlos starten →